Jefferies Group’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-13,100
Closed -$1.27K 1652
2020
Q2
$1.27K Buy
13,100
+7,300
+126% +$609K 0.01% 702
2020
Q1
$272K Hold
5,800
﹤0.01% 1560
2019
Q4
$423K Buy
5,800
+2,500
+76% +$152K ﹤0.01% 1917
2019
Q3
$172K Buy
+3,300
New +$175K ﹤0.01% 2412

Other funds holding MYOK

Jefferies Group's MYOK Position: Q3 2020 in Review

Jefferies Group sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 6,684 shares — an estimated $646 sold.

Jefferies Group first reported a position in MYOK in Q1 2020 and held it in 2 quarters. The position peaked at $18K in Q1 2020. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

  • Jefferies Group reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Jefferies Group sold 6,684 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $646.
  • Jefferies Group first reported a position in MyoKardia, Inc. Common Stock in Q1 2020 and held it in 2 quarters.
  • Jefferies Group's MyoKardia, Inc. Common Stock position peaked at $18K in Q1 2020.
  • 237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on Jefferies Group's 13F filing for Q3 2020, filed 13 Nov 2020.